BRANDY BARTHOLOMEW: Open Payments
NPI 1063802346 · LEXINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,608 in 73 payments from 21 companies in 2025. Trend: 2023 $1,863 · 2024 $2,094 · 2025 $1,608
Food & beverage: $1,608
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $328 |
| UCB, Inc. | 8 | $223 |
| Biogen, Inc. | 9 | $201 |
| Eisai Inc. | 5 | $89 |
| ARGENX US, INC. | 4 | $88 |
| SK Life Science, Inc. | 3 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $69 |
| TG Therapeutics, Inc. | 2 | $68 |
| Lundbeck LLC | 3 | $62 |
| Amneal Pharmaceuticals LLC | 3 | $62 |
Products named: KESIMPTA, VUMERITY, Leqembi, VYVGART HYTRULO, Zilbrysq, Nayzilam, INGREZZA, BRIUMVI.
Industry payments across TN — which companies pay providers there.
